ABSTRACT In the past five years, inclusion body hepatitis-hydropericardium syndrome caused by fowl adenovirus type 4 (FAdV-4) has been rampant in China and is still an epidemic at present. We had found the contamination of FAdV-4 in Newcastle disease virus (NDV)-attenuated vaccine from a large farm with aforementioned disease, and then conjectured that the use of this contaminated vaccine might be an important reason for the outbreak of the FAdV-4 infection. To assess the pathogenicity of this contaminated vaccine and the interaction between FAdV and LaSota, systemic animal experiments were launched with FAdV infection via the contaminated vaccine, as well as FAdV direct infection. Results showed that no chicks died after FAdV direct infection, while a 16.7% mortality rate appeared after FAdV infection through the contaminated vaccine; the synergistic reaction of FAdV and LaSota aggravated their inhibitory action for weight growth of SPF chickens, enhanced one another's capacity for immune system destruction, promoted their multiplication in vivo, and restrained antibody production. This study demonstrated the intracorporal interaction and enhanced pathogenicity of FAdV-4 and LaSota strain in contaminated NDV-attenuated vaccine, illustrating how the exogenous virus causes infection and induces severe diseases, which reminds us that the damage of attenuated vaccine contaminated with FAdV-4 even in extremely low dose is not insignificant. 
INTRODUCTION
Since 2013, an avian disease characterized by an accumulation of fluid in the pericardial sac and inclusion body hepatitis has appeared in Shandong, Henan, Hebei, and other provinces of China. After a large number of epidemiological investigations, the etiology was determined to be fowl adenovirus type 4 (FAdV-4; Liu et al., 2016; Zhang et al., 2016; Chen et al., 2017; Pan et al., 2017) . However, Toro found approximately 40% FAdV-positive rate of healthy chickens in flocks with inclusion body hepatitis-hydropericardium syndrome (IBH-HPS), demonstrating that FAdV-4 was not the only etiological agent for this disease and needed synergistic reaction from other pathogens (Toro et al., 1999) .
Until present, the source of infection of FAdV-4 for different flocks-especially flocks with high biological safety conditions-has been unclear, while the use of attenuated vaccines contaminated with FAdV-4 was suspected as one of the sources of infection (Li et al., 2017a) . However, the dose of exogenous virus contamination in attenuated vaccine was extremely low in the ordinary course of events, and we are interested in the pathogenicity differences between FAdV infection through contaminated vaccine and FAdV direct infection at the same low dosage. Accordingly, systemic animal experiments were launched to observe the intracorporal interaction and enhanced pathogenicity of fowl adenovirus and LaSota strain in contaminated Newcastle disease virus (NDV)-attenuated vaccine.
METHODS AND MATERIALS

Ethics Statement
The animal care and use protocol was approved by the Shandong Agricultural University Animal care 613 
Vaccine backgroud
In the second half of 2015, the highest mortality from severe FAdV-4 infection appeared on a large-scale poultry farm. The possibility of horizontal transmission was very small with a reliable external quarantine standard and no exotic chickens. To ensure the association between the disease and vaccine contamination, corresponding real-time fluorescence quantitative polymerase chain reactions (rt-qPCR) were conducted for the detection of avian leukosis virus (ALV), reticuloendotheliosis virus (REV), FAdV, and chicken infectious anemia virus (CIAV) in the attenuated vaccines from this farm (Günes et al., 2012; Dai et al., 2015; Luan et al., 2016; Ren et al., 2016) . Surprisingly, the results showed the contamination of FAdV in the NDVattenuated vaccine, which was then determined to be FAdV-4, named as SDAUF-N1, by sequencing and analysis of its hexon gene. Thus we speculated that the use of such contaminated vaccine might be an important reason for the outbreak of FAdV-4 in that poultry farm.
Isolation and Quantification of FAdV
In our laboratory, according to similar methods described in the previous report , 1 mL of vaccine seed was mixed well with 1 mL of NDV-specific serum (prepared by the China Institute of Veterinary Drug Control), and the mixtures were shaken and incubated at 37
• C for 60 min for neutralization and filtered through a 0.22-μm filter. The filtered solution was used to inoculate 10-day-old SPF embryonated chicken eggs and then the allantoic fluid was gathered around 4-6 days post infection. After repeated neutralization, the isolate of FAdV was detected by rt-qPCR for the existence of NDV (Jang et al., 2011) . The titer of this FAdV isolate was measured by egg inoculation using the ReedMuench method and is presented as the EID 50 /0.1 mL (Zhao et al., 2015) .
Animal Experimental Design
One-day-old SPF chickens (SPAFAS poultry company, Jinan, China) were wing banded and randomly divided into six groups. Each group had 15 chickens, which were separately bred in shielded cages with positive filtered air. NDV-attenuated vaccines (all negative in common pathogens test) with two different doses of SDAUF-N1 strain were prepared for oral vaccination at seven days age, while SDAUF-N1 strain at the same doses were also diluted with phosphate buffered saline (PBS) for the same operation. Specific groups and treatments are shown in Table 1 .
Measurement of Body Weight and Immune Organs Indices
To compare the effects of viral infection on growth retardation and immunosuppression, the growth and death of the chicks were measured daily. Individual body weights (BWs) were measured at wk 1, 2, 3, 4, 5, and 6 in the six groups of the experiment. At 3 wk of age, 3 chicks of each group were randomly chosen and euthanized, and the tissues were collected including the thymus, spleen, and bursa of Fabricius and preserved at −80
• C. At 6 wk of age, samples of thymus, spleen, and bursa of Fabricius were excised from all chicks and weighed to establish immune organ indices. After weighing the organs, the immune organ indices of the thymus, spleen, and bursa of Fabricius were calculated as organ weight (wet weight, mg)/BW (g) × 100%.
Quantification of Viral Load
At 3 wk of age, 3 chicks of each group were randomly chosen and euthanized, and the tissues were collected including the lung, weasand, heart, liver, thymus, spleen, and bursa of Fabricius for RNA extraction (Omega Bio-Tek, Norcross, GA) to determine the LaSota viral load in different organs according previous published methods (Jang et al., 2011) . Meanwhile, genome DNA was also extracted from those organs by DNA extraction kit (Omega Bio-Tek) for the quantification of FAdV viral load using published rtqPCR methods (Günes et al., 2012) . On the other hand, anticoagulant from all chicks was collected at 10, 14, 21, 28, and 35 days post hatched of the experiment for DNA extraction to determine the viremia level of FAdV. The rt-qPCR reactions were set up on ice, and an ABI PRISMR 7500 Sequence Detection System (Applied Biosystems, USA) was used to amplify and detect the reaction products. The rt-qPCR was performed Figure 2. LaSota viral loads in different organs. Different organs were excised from 3 chicks randomly chosen from each group at 3 wk age to determine the LaSota viral load, which was represented as Log 10 copies/μl (Mean value ± error). The NDV Viral Load value of contaminated group was compared with that of the corresponding non-contaminated group ( * P < 0.05) based on Duncan's multiple-range test.
in duplicate, with each sample present in technical duplicate during each run.
Antibody Responses to NDV and FAdV
Sera from all chicks were collected at wk 2, 3, 4, 5, and 6 of the experiment for hemagglutination inhibition testing to determine the concentrations of NDV antibodies in accordance with the routine procedures, while the FAdV antibody level of those samples were also determined using the FAdV Group I Antibody test kit (BioChek, Netherlands) according to the instructions.
Statistical Analysis
Statistical analysis was performed using the SPSS statistical software package for Windows version 17.0 (SPSS Inc. Chicago, Illinois, USA). P < 0.05 was considered statistically significant based on Duncan's multiple-range test.
RESULTS
Mortality Rates and Clinical Symptom
In the whole experiment, the mortality rate of group LaSota/FAdV/HD and group LaSota/FAdV/LD were 16.7% and 8.3%, respectively, and the death appeared during 35-38 days age, while no chick died in other groups. Typical inclusion body hepatitis was shown in all dead chicks ( Figure 1A and B).
Body Weights
As shown in Table 2 , no significant difference was observed between the group PBS and group LaSota (P > 0.05), which demonstrated that normal vaccination has low impact on the BWs growth of SPF chickens. But the BWs of chickens in group PBS and group LaSota were significantly higher than that of other groups (P < 0.05) at different day ages. More importantly, the BWs of chickens in group LaSota/FAdV/HD and group LaSota/FAdV/LD were apparently lower than that of group PBS/FAdV/HD and group PBS/FAdV/LD (P < 0.05), which illustrated that the interaction of FAdV and LaSota aggravated the inhibitory action for BWs growth of SPF chickens.
Immune Organs Indices
As shown in Table 3 , compared to that of the chickens from group PBS, chickens in group LaSota exhibited slight atrophy in thymus, spleen and bursa of Fabricius (P > 0.05), which demonstrated that LaSota could also disturb the development of immune organs mildly in normal vaccination. The immune system organs of other groups showed different degrees of injury, including splenomegaly and atrophy of the thymus gland, while such injury in group LaSota/FAdV/HD and group LaSota/FAdV/LD were significantly higher than that of group PBS/FAdV/HD and group PBS/FAdV/LD (P < 0.05), which showed that the interaction of FAdV and LaSota aggravated one another's capacity for immune system destruction. On the other hand, comparing with other groups, the bursa of Fabricius in group PBS/FAdV/HD and group PBS/FAdV/LD showed different degrees of swelling (P < 0.05).
FAdV Elevates the LaSota Viral Load in Some Organs
At 3 wk of age, samples of the lung, weasand, heart, liver, thymus, spleen, and bursa of Fabricius were excised from 3 chicks randomly chosen from each group for RNA extraction to determine the LaSota viral load in different organs. Results showed that the LaSota viral load in lung, weasand and bursa of Fabricius of group LaSota/FAdV/HD and group LaSota/FAdV/LD were significantly higher than that of group LaSota (P < 0.05) (Figure 2 ) as well as no significant differences among liver, spleen and thymus, while the LaSota viral load in heart of group LaSota/FAdV/HD and group LaSota/FAdV/LD were significantly lower than that of group LaSota (P < 0.05). At the same time, the more FAdV contamination dose are, the higher improvement of LaSota viral load in lung and weasand show in this experiment.
LaSota Elevates the FAdV Viral Load in Liver and Thymus
At 3 wk of age, samples of the lung, weasand, heart, liver, thymus, spleen, and bursa of Fabricius were excised from 3 chicks randomly chosen from each group for DNA extraction to test the FAdV viral load in different organs. Results showed that there was a great deal of FAdV in liver, spleen and thymus, while the FAdV viral loads of heart and bursa of Fabricius were extremely low. The FAdV viral load in liver and thymus of group LaSota/FAdV/HD and group LaSota/FAdV/LD were significantly higher than that of group PBS/FAdV/HD and group PBS/FAdV/LD (P < 0.05, Figure 3) , while the FAdV viral load in bursa of Fabricius and heart of the former were lower than that of the latter (P < 0.05). What's more, the FAdV viral load in lung and weasand were too low to detect.
LaSota Elevates the FAdV Viremia Level
FAdV viremia levels were compared between group LaSota/FAdV/HD and group PBS/FAdV/HD ( Figure 4A ) or LaSota/FAdV/LD and group PBS/FAdV/LD ( Figure 4B ) at 10 days, and 2, 3, 4, and 5 wk post hatched. Results showed that the FAdV viremia levels of LaSota/FAdV/HD were obviously higher than that of PBS/FAdV/HD (P < 0.05) all the time. The FAdV viremia levels of group PBS/FAdV/HD firstly increased and then decreased as time goes on ( Figure 4A ), which demonstrated that chicken immune system was enough to suppress the multiplication of FAdV and prevent disease progression. But the FAdV viremia levels in group LaSota/FAdV/HD showed no obvious fluctuation ( Figure 4A ). More importantly, the viremia level of LaSota/FAdV/HD was already very high at 3 days post vaccination, and we speculated that the existence of LaSota may promote the invasion of FAdV. Results about the group LaSota/FAdV/LD and group PBS/FAdV/LD were similar to the above ( Figure 4B ).
FAdV Significantly Decreases the NDV Antibody Titers
On 21, 28, 35, and 42 day post-immunization with the attenuated vaccines, antibody titers to NDV in chickens from group LaSota/FAdV/HD and LaSota/FAdV/LD were lower than that of the chickens from group LaSota (P < 0.05), respectively. At the same time, the more FAdV contamination dose are, the higher decrease of NDV antibody titers show in this experiment ( Figure 5 ). Influence of different treatments on the NDV antibody titers. Sera from all chicks were collected at different intervals of the experiment for hemagglutination inhibition testing to determine the concentrations of NDV antibody, which was represented as Log 2 NDV antibody titer (Mean value ± error). The NDV Antibody value of non-contaminated group was compared with that of the corresponding contaminated group ( * P < 0.05) based on Duncan's multiple-range test. Figure 6 . Influence of different treatments on the FAdV antibody titers. Sera from all chicks were collected at different intervals of the experiment to determine the concentrations of FAdV antibody, which was represented as Log 10 FAdV antibody titer (Mean value ± error). The FAdV Abtibody value of vaccination group was compared with that of the corresponding non-vaccination group ( * P < 0.05) based on Duncan's multiple-range test.
LaSota Significantly Decreases the FAdV Antibody Titers
Sera from all chicks were collected at weeks 2, 3, 4, 5, and 6 of the experiment to determine the concentrations of FAdV antibody. Results showed that the FAdV antibody titers in LaSota/FAdV/HD were significantly lower than that of PBS/FAdV/HD (P < 0.05, Figure 6A ), which demonstrated that LaSota could disturb and decrease the production of FAdV antibody. Results about the group LaSota/FAdV/LD and group PBS/FAdV/LD were similar to the above ( Figure 6B ).
DISCUSSION
Exogenous virus contamination in avian-attenuated vaccine is a unique source of infection for some infectious diseases. At present, most reports describing exogenous virus contamination mention ALV (Zavala and Cheng, 2006; Fadly et al., 2006a; Barbosa et al., 2008; Zhao et al., 2014) , REV (Fadly and Garcia, 2006b; Awad et al., 2010; Wei et al., 2012; Li et al., 2015; , CIAV (Yuasa et al., 1979; Li et al., 2017b) , and FAdV (Li et al., 2017a) , which share the common feature of being able to vertically propagate through the chick embryo.
Since 2013, IBH-HPS induced by FAdV-4 was rampant in China and is still an epidemic at present Zhang et al., 2016; Chen et al., 2017; Pan et al., 2017) , with the use of attenuated vaccines contaminated with FAdV-4 being suspected as one of the sources of infection. However, Toro found about 40% FAdV-positive rate of healthy chickens in flocks with IBH-HPS, demonstrating that FAdV-4 was not the only etiological agent for this disease and needed synergistic reaction from other pathogens (Toro et al., 1999) . Therefore, is the NDV-attenuated vaccine LaSota strain the promoting agent for the pathogenicity of FAdV-4? Considering the LaSota could rapidly induce noticeable respiratory symptoms and inflammatory reaction to chickens (Niu et al., 2015) , we thus speculated that the pathogenicity of NDV-attenuated vaccine with FAdV contamination is significantly different from both NDV-attenuated vaccine without contamination and pure FAdV at the same dosage. Consequently, systemic animal experiments were launched to observe the intracorporal interaction and enhanced pathogenicity of FAdV-4 and LaSota strain in contaminated NDV-attenuated vaccine.
Using FAdV isolated from above-mentioned vaccine, contaminated vaccines and corresponding virus PBS diluent were artificially prepared as trial samples in this study, simulation experiments were then performed with those samples through the mouth to chickens. Interestingly, no chickens died after orally taking FAdV PBS diluent, while a mortality rate of approximately 16.7% appeared after taking vaccine contaminated with FAdV orally at the same quantity, demonstrating that the synergistic reaction of FAdV and LaSota improved the pathogenicity to SPF chickens of one another. Moreover, such synergistic reaction also aggravated the inhibitory action for BWs growth of SPF chickens and even enhanced one another's capacity for immune system destruction.
As an exogenous contaminated virus, the effects of FAdV on LaSota were evident, decreasing the NDV antibody titers and reducing its protective effectiveness. On the contrary, the effects of LaSota on FAdV were more significant. Especially at the early period after vaccination, the existence of vaccine promoted the invasion of FAdV, potentially laying the foundations for the further multiplication of it. Meanwhile, we conjectured that LaSota, with high adaptability and multiplication capacity in vivo, could occupy major immune system and then decrease its response to FAdV, reducing the production of FAdV antibody and lessening the inhibitory action on its multiplication. All of those enhanced the pathogenicity of FAdV and induced severe clinical symptoms.
The rapid proliferation of FAdV in vivo could also damage the immune system and restrain the humoral immunity, providing an advantage for the further multiplication of FAdV or LaSota and even the emergence of secondary infections. We tested the viral load of LaSota in different organs, and found that, with the help of FAdV, it significantly improved in lung, weasand, and bursa of Fabricius. However, attenuated vaccine as LaSota is, the pathogenicity of it with overmuch viral load level could not be ignored (Niu et al., 2015) .
It is believed that FAdV and LaSota play respective but related roles in vivo, then improving one another's pathogenicity under complex interactions. FAdV-4 could damage the liver and then induce the inclusion body hepatitis (Li et al., 2017c) , while LaSota might cause systemic inflammation and respiratory symptoms (Niu et al., 2015) . Meanwhile, the immune system was unable to produce enough antibodies to resist the multiplication of FAdV and LaSota under their synergistic reaction, providing opportunities for them to mass multiply and then cause severe clinical symptoms.
In conclusion, this study observed the change of NDV-attenuated vaccine LaSota under the contamination of FAdV, as well as the influences of LaSota on FAdV in vivo, and finally demonstrated that the intracorporal interaction of FAdV and LaSota elevates the pathogenicity of one another, illustrating how the exogenous low dose virus causes infection and induces severe diseases. More importantly, this study reminds us to pay close attention to the co-pathogenicity of attenuated vaccine and contaminated exogenous virus within, and vaccine users should strengthen the test of attenuated vaccines before use to avoid similar problems in the future.
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